CRY Stock Price, Chart, Stats & News

Artivion, Inc.
Save
CRY chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 64.40% |
Operating margin | 7.65% |
Pretax margin | 3.35% |
Net margin | 2.21% |
Effective tax rate | 33.91% |
ROA | – |
ROE | 2.44% |
D/E | 0.02x |
Interest coverage ratio | 1.27x |
CRY valuation
P/E | 425.71x |
P/S | 1.64x |
P/B | 1.90x |
P/CF | 21.32x |
P/FCF | 864.30x |
P/OCF | 21.32x |
PEG | 1.74x |
EV multiple | 21.25x |
About
Artivion Inc., established in 1984 and based in Kennesaw, Georgia, functions globally as a manufacturer, processor, and distributor of both medical devices and implantable human tissues. Previously known as CryoLife, Inc., the company underwent a rebranding to Artivion Inc. in January 2022. Artivion caters to a wide array of clients, including physicians, hospitals, various healthcare facilities, and specialized surgeons in cardiac, vascular, thoracic, and general fields.
Similar securities
Based on sector and market capitalization
Report issue











